A 44-year-old man was treated with amiodarone for dilated cardiomyopathy. After 53 months, he developed amiodarone-induced interstitial pneumonia. Amiodarone treatment was terminated, and the patient was given corticosteroids. These treatments were effective. However, pneumonitis recurred whenever prednisolone was reduced to less than 5 mg per day. Considering the patient's background characteristics, we considered his body mass index (BMI, kg/m2) and found his to be high. When four additional patients with amiodarone pulmonary toxicity were reviewed at our institute, a correlation between BMI and the duration of shadow disappearance was found (R2=0.8695). Because amiodarone is lipophilic, the patient's high BMI might have influenced the repeated appearance of pulmonary toxicity. © 2006 The Japanese Society of Internal Medicine.
CITATION STYLE
Okayasu, K., Takeda, Y., Kojima, J., Yoshizawa, A., Kobayashi, N., Sugiyama, H., & Kudo, K. (2006). Amiodarone pulmonary toxicity: A patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. Internal Medicine, 45(22), 1303–1307. https://doi.org/10.2169/internalmedicine.45.1800
Mendeley helps you to discover research relevant for your work.